Susan Smith-Harmon
Phase 2 of Arch grounds re-do finds funding
Thursday, 21 February 2013 08:30 Published in Around TownCrews had already planned to begin construction of the "lid" over I-70.
Now, the rebuild of Leonor K. Sullivan Boulevard, which runs along the riverfront at the base of the Arch steps, will also start this year. The road will be elevated and redesigned to include bike paths and pedestrian walkways.
Funding had already been in place for the $47 million park that will cap the highway. Newly found savings from that project will help fund the other.
The St. Louis Post-Dispatch reports that engineers have determined that the concrete walls of the "depressed section" of I-70 don’t need to be replaced, as originally thought. So the $11-million cost savings on that project will fund the Leonor K. Sullivan rebuild.
Phase 2 of Arch grounds re-do finds funding
Thursday, 21 February 2013 04:34 Published in Local NewsCrews had already planned to begin construction of the "lid" over I-70.
Now, the rebuild of Leonor K. Sullivan Boulevard, which runs along the riverfront at the base of the Arch steps, will also start this year. The road will be elevated and redesigned to include bike paths and pedestrian walkways.
Funding had already been in place for the $47 million park that will cap the highway. Newly found savings from that project will help fund the other.
The St. Louis Post-Dispatch reports that engineers have determined that the concrete walls of the "depressed section" of I-70 don’t need to be replaced, as originally thought. So the $11-million cost savings on that project will fund the Leonor K. Sullivan rebuild.
Ellisville City Council moves ahead with Mayor's impeachment
Thursday, 21 February 2013 02:10 Published in Local NewsThe move comes just two days after the Ellisville Charter Enforcement Commission unanimously recommended that the impeachment complaint be thrown out.
Ironically, it's Martin who will present the resolution at the March 6th council meeting.
The specifics of the complaint against the mayor haven't been released, but Martin has clashed frequently with other council members over a controversial Walmart TIF that was passed last year. Martin had been elected last spring after campaigning against the TIF.
The mayor's attorney, Chet Pleban, says the impeachment effort will be met with litigation.
Latest News
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8

First lady's anti-obesity campaign is prompting change
WASHINGTON (AP) - Walmart is putting special labels on some store-brand products to help shoppers quickly spot healthier items. Millions of schoolchildren are helping themselves to...

C. EVERETT KOOP, 'ROCK STAR' SURGEON GENERAL, DIES
NEW YORK (AP) -- Dr. C. Everett Koop has long been regarded as the nation's doctor- even though it has been nearly a quarter-century since he was surgeon general. Koop, who died...

UK STUDY: VIOLENCE MORE LIKELY AMONG VETS, TROOPS
LONDON (AP) -- Young men who have served in the British military are about three times more likely than civilians to have committed a violent offense, researchers reported Friday i...

PANEL QUESTIONS VALUE OF CALCIUM, VITAMIN D PILLS
WASHINGTON (AP) -- Popping calcium and vitamin D pills in hopes of strong bones? Healthy older women shouldn't bother with relatively low-dose dietary supplements, say new recommen...

MEDITERRANEAN-STYLE DIETS FOUND TO CUT HEART RISKS
Pour on the olive oil, preferably over fish and vegetables: One of the longest and most scientific tests of a Mediterranean diet suggests this style of eating can cut the chance of...

ADULTS GET 11 PERCENT OF CALORIES FROM FAST FOOD
ATLANTA (AP) -- On an average day, U.S. adults get roughly 11 percent of their calories from fast food, a government study shows. That's down slightly from the 13 percent report...

COURT: CAN HUMAN GENES BE PATENTED?
WASHINGTON (AP) -- DNA may be the building block of life, but can something taken from it also be the building block of a multimillion-dollar medical monopoly? The Supreme Court...

FDA APPROVES RETURN OF DRUG FOR MORNING SICKNESS
WASHINGTON (AP) -- Talk about a comeback: A treatment pulled off the market 30 years ago has won Food and Drug Administration approval again as the only drug specifically designate...